Article

STAAR's ICL wins spot on FDA's fast-track list

Monrovia, CA-The FDA is studying STAAR Surgical Co.'s implantable contact lens (ICL) under an expedited review status that calls the product a potentially revolutionary advance over the current market.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Related Content
Q&A: Understanding the influences on molecular confirmation after genetic testing for IRDs
August 13th 2025

Q&A: Understanding the influences on molecular confirmation after genetic testing for IRDs

3 Things You Should Know About the GA Pipeline
August 13th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Lupin and Sandoz sign licensing deal for biosimilar ranibizumab across multiple regions
August 13th 2025

Lupin and Sandoz sign licensing deal for biosimilar ranibizumab across multiple regions

Patient-Centered Treatment Strategies in the Management of nAMD and DME
August 13th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

(Image credit: AdobeStock/ipopba) Robotic precision: Elevating the state of laser cataract surgery
August 13th 2025

Robotic precision: Elevating the state of laser cataract surgery

(Image credit: AdobeStock/zabhie) AI applications in cataract surgery: A surgeon’s perspective
August 13th 2025

AI applications in cataract surgery: A surgeon’s perspective

© 2025 MJH Life Sciences

All rights reserved.